COMMUNIQUÉS West-GlobeNewswire

-
Lexicon Appoints Scott Coiante as Chief Financial Officer
02/01/2025 -
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025 -
GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing
02/01/2025 -
SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET
02/01/2025 -
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025 -
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
02/01/2025 -
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
02/01/2025 -
Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics
02/01/2025 -
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
02/01/2025 -
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025 -
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
02/01/2025 -
Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference
02/01/2025 -
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
02/01/2025 -
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
02/01/2025 -
BioStem Technologies CEO to Present at Biotech Showcase 2025
02/01/2025 -
ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
02/01/2025 -
The Ensign Group Closes on Expansion in Tennessee, Adds Its First Operation in Alabama
02/01/2025 -
Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.
02/01/2025 -
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy
02/01/2025
Pages